文献速递乳腺癌放疗放疗物理与技术

左乳腺癌患者深吸气屏气技术下基于切线野的容积旋转调强放疗剂量学分析

Dosimetric analysis of tangent-based volumetric modulated arc therapy with deep inspiration breath-hold technique for left breast cancer patients.
PubMed 文献 · Radiat Oncol · 2018-11-26

本研究纳入14例左乳腺癌保乳术后患者,对比深吸气屏气(DIBH)与自由呼吸(FB)下基于切线野的容积旋转调强放疗(TVMAT)及DIBH下基于切线野的调强放疗(TIMRT)的剂量学特征。结果显示DIBH-TVMAT较FB-TVMAT降低心脏平均剂量(7.9 Gy降至3.2 Gy,p<0.001)和左肺V30Gy(12.9%降至5.7%,p<0.001),较DIBH-TIMRT降低左肺V30Gy(8.5%降至5.7%,p=0.031)。作者认为DIBH-TVMAT保持与DIBH-IMRT相似的计划质量,不牺牲心脏、右乳和右肺的剂量限制,但右乳和心脏V5Gy仍较高。

要点

  • DIBH-TVMAT较FB-TVMAT显著降低心脏平均剂量(7.9 Gy降至3.2 Gy,p<0.001)和左肺V30Gy(12.9%降至5.7%,p<0.001)。
  • DIBH-TVMAT较DIBH-TIMRT降低左肺V30Gy(8.5%降至5.7%,p=0.031)。
  • DIBH-TVMAT右乳和心脏V5Gy仍较高,低剂量区左肺、右乳、心脏和右肺V10Gy与IMRT计划无显著差异。

核心结论

  • DIBH-TVMAT用于左乳腺癌治疗保持与DIBH-IMRT技术相似的计划质量,不牺牲心脏、右乳和右肺的剂量限制。
  • DIBH-TVMAT增加左肺保护,但右乳V5Gy仍较高,心脏V5Gy明显更高。
  • 作者认为对于接受DIBH技术治疗的左乳腺癌患者,DIBH-TVMAT提供更好的治疗质量,是一种安全可行的治疗策略。

研究设计与样本

  • 纳入14例左乳腺癌保乳术后患者,比较TVMAT与TIMRT在DIBH和FB技术下的剂量学特征。
  • TVMAT计划第一弧起始331.8-353.6度、停止281.8-315.0度,第三弧起始123.2-149.1度、停止88.0-96.0度,第二和第四弧分别为第一和第三弧的反向弧。
  • DIBH-TIMRT逆向计划采用对穿切线野生成,使用Wilcoxon符号秩检验和Spearman相关分析剂量差异的显著性。

主要发现

  • DIBH-TVMAT较FB-TVMAT心脏平均剂量从7.9 Gy降至3.2 Gy(p<0.001),左肺V30Gy从12.9%降至5.7%(p<0.001)。
  • DIBH-TVMAT较FB-TVMAT对侧乳腺和对侧肺平均剂量更低(2 Gy和0.7 Gy vs 3.4 Gy和1.5 Gy)。
  • DIBH-TVMAT较DIBH-TIMRT左肺V30Gy从8.5%降至5.7%(p=0.031)。
  • 低剂量区方面,IMRT与VMAT计划间左肺、右乳、心脏和右肺V10Gy无显著差异。

关键数值与推荐

  • DIBH-TVMAT较FB-TVMAT心脏平均剂量7.9 Gy vs 3.2 Gy(p<0.001)。
  • DIBH-TVMAT较FB-TVMAT左肺V30Gy 12.9% vs 5.7%(p<0.001)。
  • DIBH-TVMAT较FB-TVMAT对侧乳腺平均剂量2 Gy vs 3.4 Gy,对侧肺平均剂量0.7 Gy vs 1.5 Gy。
  • DIBH-TVMAT较DIBH-TIMRT左肺V30Gy 8.5% vs 5.7%(p=0.031)。

临床怎么用

  • 作者认为对于接受DIBH技术治疗的左乳腺癌患者,DIBH-TVMAT提供更好的治疗质量,是一种安全可行的治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tangent-based intensity modulated radiation therapy (TIMRT) is a common adjuvant radiotherapy strategy for breast cancer patients. This study compared the dosimetric characteristics of tangent-based volumetric modulated arc therapy (TVMAT) and TIMRT for left breast cancer patients during deep inspiration breath-hold (DIBH) and free breathing (FB) techniques. METHODS: Fourteen patients with left breast cancer after breast-conserving surgery were included. The first arc started at 331.8-353.6 degrees and stopped at 281.8-315.0 degrees. The third arc started at 123.2-149.1 degrees and stopped at 88.0-96.0 degrees. The second and fourth arcs were reverse arcs of first and third arcs. DIBH-TIMRT inversing plans were generated using opposing tangential fields. Wilcoxon signed rank test and Spearman correlation were used to examine the significance of dose difference. RESULTS: Compared with FB-TVMAT, the mean heart dose of DIBH-TVMAT plans was reduced from 7.9 Gy to 3.2 Gy (p < 0.001). The average left lung volume receiving 30 Gy or more (V30Gy) was reduced from 12.9 to 5.7% (p < 0.001). DIBH-TVAMT plans resulted in a lower mean dose to the contralateral breast and lung (2 Gy and 0.7 Gy vs 3.4 Gy and 1.5 Gy, respectively) as compared to FB-TVMAT plans. Compared with DIBH-TIMRT, the average left lung V30Gy of DIBH-TVMAT plans was reduced from 8.5 to 5.7% (p = 0.031). As for low-dose areas, exposure of the left lung, right breast, heart and right lung volume with 10 Gy or more was not significantly different between the IMRT- and VMAT-plans. CONCLUSIONS: DIBH-TVMAT for left breast cancer treatment retains treatment plan quality similar to the DIBH-IMRT technique without compromising dose restrictions to the heart, right breast and right lung. DIBH-TVMAT increased left lung protection but still had higher V5Gy to right breast and substantially higher V5Gy to heart. For left breast cancer patients receiving treatment with the DIBH technique, DIBH-TVMAT provides better treatment quality and is a safe and feasible treatment strategy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yu PC, Wu CJ, Tsai YL, et al. Dosimetric analysis of tangent-based volumetric modulated arc therapy with deep inspiration breath-hold technique for left breast cancer patients. Radiat Oncol. 2018. PMID: 30477511. doi:10.1186/s13014-018-1170-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。